The pathogenic correlation between Shc/Grb2 binding to AβPP during AD development is supported by the observation that the complexes AβPP (or CTFs)/ShcA or Grb2 are significantly increased in AD brain as compared to controls [55]. Here, GRB2 is linked to Alzheimer disease.